comparemela.com

Latest Breaking News On - தேசிய மருந்து ஒழுங்குமுறை பிரிவு - Page 6 : comparemela.com

Mestron clarifies it does not have MoH s approval to distribute Covid-19 vaccines in Malaysia

Mestron clarifies it does not have MoH s approval to distribute Covid-19 vaccines in Malaysia The Edge 31/1/2021 Syahirah Syed Jaafar © Provided by The Edge KUALA LUMPUR (Jan 31): Mestron Holdings Bhd has issued a clarification to say that it did not obtain approval or a clearance letter from the Ministry of Health (MoH) to purchase or distribute Covid-19 vaccines in Malaysia. Instead, it clarified that its intention is to explore and venture into the vaccine distribution business by partnering with China-based Zhongyu Yexing (Chengdu) Industrial Co Ltd. The steel pole maker said this in a statement today after the MoH denied granting approval or issuing letters of permission to private parties for this purpose.

MOH denies issuing vaccine distribution authorisation letter

MOH inks term sheet agreements with two vaccine suppliers

MOH inks term sheet agreements with two vaccine suppliers 26 Jan 2021 / 21:35 H. KUALA LUMPUR: The Ministry of Health (MOH) today signed term sheet agreements with two vaccine suppliers, Pharmaniaga Lifescience Sdn Bhd (PLS) and Duopharma (M) Sdn Bhd for the procurement of 18.4 million doses of Covid-19 vaccine for 28.75 per cent of the Malaysian population. MOH, in a statement today said PLS would supply 12 million doses of Covid-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell) Inactivated produced by Sinovac Life Science Co. Ltd, which would be distributed in stages beginning April. “Duopharma will supply 6.4 million doses of Sputnik V vaccine, produced by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine is expected to be distributed in stages by end-March 2021,” it said.

Health Ministry inks agreements with vaccine suppliers

Health Ministry inks agreements with vaccine suppliers January 26, 2021 KUALA LUMPUR – The Ministry of Health (MOH) today signed term sheet agreements with two vaccine suppliers, Pharmaniaga Lifescience Sdn Bhd (PLS) and Duopharma (M) Sdn Bhd for the procurement of 18.4 million doses of COVID-19 vaccine for 28.75 per cent of the Malaysian population. MOH, in a statement today said PLS would supply 12 million doses of COVID-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell) Inactivated produced by Sinovac Life Science Co. Ltd, which would be distributed in stages beginning April. Advertisement “Duopharma will supply 6.4 million doses of Sputnik V vaccine, produced by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine is expected to be distributed in stages by end-March 2021,” it said.

Covid vaccination programme expected to be completed end of this year or early 2022 (Updated)

Covid vaccination programme expected to be completed end of this year or early 2022 (Updated) 25 Jan 2021 / 22:52 H. KUALA LUMPUR: The Health Ministry (MOH) is targetting the Covid-19 vaccination programme in the country to be completed by the end of this year or early next year. Health director-general Tan Sri Dr Noor Hisham Abdullah ( pix) said the vaccination programme would involve three phases with the first phase expected to start in March involving half a million vaccines for frontline workers. “We hope to receive the first vaccine at the end of next month. We expect the (first phase) of vaccinations to be from March to May with the second dose being administered 21 days after receiving the first dose.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.